cannabis indica

Sistema Urinário

termo de indexação original: Urinary System

O acervo do Cannabis Indica reúne 111 estudos científicos que tocam o Sistema Urinário, publicados entre 1987 e 2023. Pela leitura automatizada, 90 (81%) foram classificados como favoráveis, 14 (13%) como inconclusivos e 7 (6%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é metanálise (40 estudos), seguido de ensaio clínico (24). As condições mais estudadas dentro deste sistema são Insuficiência Renal, Doença Renal Crônica e Câncer.

Estudos indexados
111
Período coberto
1987–2023
Favoráveis
90 · 81%
Inconclusivos
14 · 13%
Desfavoráveis
7 · 6%
Termo original
Urinary System

O acervo em números

Tipo de estudo

Metanálise40
Ensaio Clínico24
Estudo em Animais23
Estudo Laboratorial13
Ensaio Clínico Duplo-Cego9
Metanálise Clínica2

Direção do resultado

Favorável90
Inconclusivo14
Desfavorável7

Por década

1980s1
1990s1
2000s9
2010s57
2020s43

111 estudos

Filtrar e buscar no acervo →
  1. 2023

    Circulating Endocannabinoid Levels as Potential Biomarkers for Mortality in Hemodialysis Patients

    FavorávelMetanáliseHemodiáliseAnandamida (AEA)2-Araquidonoilglicerol (2-AG)
  2. 2023

    Effect of Cannabidiol Oil on Post-ureteroscopy Pain for Urinary Calculi: A Randomized, Double-blind, Placebo-controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoDorInflamaçãoDor — AgudaCBD Farmacêutico+1
  3. 2023

    Systemic Changes in Endocannabinoids and Endocannabinoid-like Molecules in Response to Partial Nephrectomy-Induced Ischemia in Humans

  4. 2022

    Acute and long-term effects of cannabinoids on hypertension and kidney injury

  5. 2022

    Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer

  6. 2022

    Anti-inflammatory effects of lavender and eucalyptus essential oils on the in vitro cell culture model of bladder pain syndrome using T24 cells

    FavorávelEstudo LaboratorialInflamaçãoCistiteEndocanabinoide (não especificado)
  7. 2022

    Association between cannabis use with urological cancers: A population-based cohort study and a mendelian randomization study in the UK biobank

    FavorávelMetanáliseCâncerCâncer — PróstataCâncer — Bexiga+1
  8. 2022

    Biomarkers for the early prediction of contrast-induced nephropathy after percutaneous coronary intervention in adults: A systematic review and meta-analysis

  9. 2022

    Cannabinoids for Symptom Management in Patients with Kidney Failure: A Narrative Review

    DesfavorávelMetanáliseDorInflamaçãoAnsiedade+11
  10. 2022

    Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Proceduresv

  11. 2022

    Comparative accuracy of biomarkers for the prediction of hospital-acquired acute kidney injury: a systematic review and meta-analysis

  12. 2022

    Efficacy of overactive neurogenic bladder treatment: A systematic review of randomized controlled trials

    FavorávelMetanálise ClínicaEsclerose MúltiplaDoença de ParkinsonAVC+2
  13. 2022

    Endocannabinoid System in Polycystic Kidney Disease

  14. 2022

    Kidney Damage and Stress Biomarkers for Early Identification of Drug-Induced Kidney Injury: A Systematic Review

  15. 2022

    Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function

    InconclusivoEstudo em AnimaisDiabetesDoença Renal Crônica
  16. 2022

    Performance of urinary liver-type fatty acid-binding protein in diabetic nephropathy: A meta-analysis

  17. 2022

    Peripheral Cannabinoid-1 Receptor Blockade Ameliorates Cystitis Severity

  18. 2022

    Protective antioxidative and anti-inflammatory actions of β-caryophyllene against sulfasalazine-induced nephrotoxicity in rat

    FavorávelEstudo em AnimaisInflamaçãoEstresse OxidativoNefropatia Induzida por Medicamentos
  19. 2022

    The Ameliorate Effects of Nerolidol on Thioacetamide-induced Oxidative Damage in Heart and Kidney Tissue

  20. 2022

    The association of bladder cancer and Cannabis: A systematic review

    InconclusivoMetanáliseCâncerCâncer — Bexiga
  21. 2022

    The Nutraceutical Antihypertensive Action of C-Phycocyanin in Chronic Kidney Disease Is Related to the Prevention of Endothelial Dysfunction

  22. 2022

    The perceptions and beliefs of cannabis use among Canadian genitourinary cancer patients

    FavorávelMetanáliseCâncerCâncer — PróstataCâncer — Bexiga+1
  23. 2021

    (+)-trans-Cannabidiol-2-hydroxy pentyl is a dual CB 1 R antagonist/CB 2 R agonist that prevents diabetic nephropathy in mice

    FavorávelEstudo em AnimaisDorDiabetesSíndrome Metabólica+3
  24. 2021

    [Droghe d'abuso e rene] Drugs of Abuse and the Kidney

  25. 2021

    A New Clinical Utility for Tubular Markers to Identify Kidney Responders to Saxagliptin Treatment in Adults With Diabetic Nephropathy

  26. 2021

    Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox

    FavorávelMetanáliseDoença Renal CrônicaEndocanabinoide (não especificado)
  27. 2021

    Cannabinoids in Urology. Which Benign Conditions Might They Be Appropriate to Treat: A Systematic Review

    InconclusivoMetanáliseCistiteIncontinência Urinária
  28. 2021

    Cannabis-Derived Compounds Cannabichromene and Δ9-Tetrahydrocannabinol Interact and Exhibit Cytotoxic Activity against Urothelial Cell Carcinoma Correlated with Inhibition of Cell Migration and Cytoskeleton Organization

    FavorávelEstudo LaboratorialCâncerCâncer — BexigaTetraidrocanabinol (THC)Canabicromeno (CBC)
  29. 2021

    CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder

  30. 2021

    Components of the Endogenous Cannabinoid System as Potential Biomarkers for Interstitial Cystitis/Bladder Pain Syndrome

  31. 2021

    Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial

  32. 2021

    Geraniol protects against cyclosporine A-induced renal injury in rats: Role of Wnt/β-catenin and PPARγ signaling pathways

    FavorávelEstudo em AnimaisDoença Renal Crônica
  33. 2021

    Gut barrier and microbiota changes with glycine and branched-chain amino acid supplementation in chronic haemodialysis patients

    DesfavorávelEnsaio Clínico Duplo-CegoInflamaçãoInsuficiência RenalAnandamida (AEA)Endocanabinoide (não especificado)+4
  34. 2021

    Nephrologist Views Regarding Cannabinoid Use in Advanced Chronic Kidney Disease and Dialysis: A Survey

    FavorávelMetanáliseCâncerInsuficiência RenalDoença Renal Crônica+4
  35. 2021

    Phycocyanobilin is the molecule responsible for the nephroprotective action of phycocyanin in acute kidney injury caused by mercury

    FavorávelEstudo em AnimaisInsuficiência RenalFicocianina
  36. 2021

    Use of cannabis in urological cancer patients: A review to evaluate risk for cancer development, therapeutic use, and symptom management

    InconclusivoMetanáliseCâncerCâncer — PróstataCâncer — Bexiga+2
  37. 2021

    β-Caryophyllene induces apoptosis and inhibits cell proliferation by deregulation of STAT-3/mTOR/AKT signaling in human bladder cancer cells: An in vitro study

    FavorávelEstudo LaboratorialCâncerCâncer — Bexiga
  38. 2021

    β-Caryophyllene may attenuate hyperoxaluria-induced kidney dysfunction in rats by regulating stress marker KIM-1/MCP-1 and NF-κB signaling pathway

    FavorávelEstudo em AnimaisInsuficiência Renal
  39. 2020

    A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment

  40. 2020

    Changes in Novel AKI Biomarkers after Exercise. A Systematic Review

  41. 2020

    Dual inhibition of cannabinoid CB 1 receptor and inducible NOS attenuates obesity-induced chronic kidney disease

  42. 2020

    Effects of exercise on residual renal function in patients undergoing peritoneal dialysis: A post-hoc analysis of a randomized controlled trial

  43. 2020

    The urothelium, the urinary microbioma and men LUTS: a systematic review

    FavorávelMetanáliseInfecção UrináriaEndocanabinoide (não especificado)
  44. 2019

    A Review of Cannabis in Chronic Kidney Disease Symptom Management

    FavorávelMetanáliseDoença Renal CrônicaTHC:CBD Farmacêutico
  45. 2019

    Cannabis Impacts Tumor Response Rate to Nivolumab in Patients with Advanced Malignancies

    InconclusivoMetanáliseCâncerCâncer — PulmãoCâncer — Melanoma+1
  46. 2019

    Fatty Acid Amide Hydrolase Inhibition Normalises Bladder Function and Reduces Pain Through Normalising the Anandamide/Palmitoylethanolamine Ratio in the Inflamed Bladder of Rats

    FavorávelEstudo em AnimaisCistiteAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+1
  47. 2019

    Micronized Palmitoylethanolamide-Polydatin Reduces the Painful Symptomatology in Patients with Interstitial Cystitis/Bladder Pain Syndrome

    FavorávelEnsaio ClínicoDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+3
  48. 2019

    Monoacylglycerol lipase inhibition as potential treatment for interstitial cystitis

    FavorávelEstudo em AnimaisCistite2-Araquidonoilglicerol (2-AG)
  49. 2019

    Systematic review of the potential role of cannabinoids as antiproliferative agents for urological cancers

  50. 2019

    The Association Between Tetrahydrocannabinol and Lower Urinary Tract Symptoms Utilizing the National Health and Nutrition Examination Survey

    FavorávelMetanáliseInfecção Urinária
  51. 2019

    The effects of delta-9-tetrahydrocannabinol on Krüppel-like factor-4 expression, redox homeostasis, and inflammation in the kidney of diabetic rat

    FavorávelEstudo em AnimaisInflamaçãoDiabetesNefropatia Diabética
  52. 2018

    Chronic Pain Treatment With Cannabidiol in Kidney Transplant Patients in Uruguay

    FavorávelEnsaio ClínicoDorInflamaçãoDor — Crônica+2
  53. 2018

    Impact of cannabidiol treatment on regulatory T-17 cells and neutrophil polarization in acute kidney injury

  54. 2018

    Involvement of the CB2 cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212–2 in renal cell carcinoma.

  55. 2018

    Medical marijuana for urologic chronic pelvic pain.

    FavorávelMetanáliseCistiteTetraidrocanabinol (THC)Canabicromeno (CBC)
  56. 2018

    Potential of Endocannabinoids to Control Bladder Pain.

    FavorávelMetanáliseCistiteAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  57. 2017

    Bladder Cancer Cell Growth and Motility Implicate Cannabinoid 2 Receptor-Mediated Modifications of Sphingolipids Metabolism

    FavorávelEstudo LaboratorialCâncerCâncer — BexigaCanabinoides Sintéticos JWH-x
  58. 2017

    Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.

    FavorávelEstudo em AnimaisNefropatia DiabéticaCanabinoides Sintéticos AM-x
  59. 2017

    Fatty Acid Amide Hydrolase Inhibitor Treatment in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: An Adaptive Double-blind, Randomized Controlled Trial

    InconclusivoEnsaio Clínico Duplo-CegoInfecção UrináriaHidrolase de Amidas de Ácidos Graxos (FAAH)
  60. 2017

    Obesity-Related CKD: When Kidneys Get the Munchies

    InconclusivoMetanáliseObesidadeDoença Renal Crônica
  61. 2017

    The efficacy of an association of palmitoylethanolamide and alpha-lipoic acid in patients with chronic prostatitis/chronic pelvic pain syndrome: A randomized clinical trial

    FavorávelEnsaio ClínicoDorInflamaçãoDor — CrônicaPalmitoiletanolamida (PEA)+2
  62. 2016

    Association between Plasma Endocannabinoids and Appetite in Hemodialysis Patients: a Pilot Study.

    FavorávelMetanáliseHemodiáliseAnandamida (AEA)Outros Compostos Relacionados
  63. 2016

    Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats

    FavorávelEstudo em AnimaisInfecção UrináriaCanabinoides Sintéticos CP-x
  64. 2016

    Effects of Tangshen Formula on urinary and plasma liver-type fatty acid binding protein levels in patients with type 2 diabetic kidney disease: post-hoc findings from a multi-center, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of Tangshen Formula in patients with type 2 diabetic kidney disease

  65. 2016

    Impact of teneligliptin on oxidative stress and endothelial function in type 2 diabetes patients with chronic kidney disease: a case-control study

  66. 2016

    New therapeutic strategies for the treatment of male lower urinary tract symptoms

    FavorávelMetanáliseInfecção Urinária
  67. 2016

    The endocannabinoid system - a target for the treatment of LUTS?

    FavorávelMetanáliseInfecção UrináriaEndocanabinoide (não especificado)
  68. 2016

    The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory.

    FavorávelMetanáliseCâncerCâncer — Rim
  69. 2015

    Association Between Cannabis Use And The Risk Of Bladder Cancer: Results From The California Men's Health

    FavorávelMetanáliseCâncerCâncer — Bexiga
  70. 2015

    Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass

  71. 2015

    Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury.

    FavorávelMetanáliseInsuficiência RenalAnandamida (AEA)
  72. 2015

    Regulation of inflammation and proliferation of human bladder carcinoma cells by type-1 and type-2 cannabinoid receptors

  73. 2015

    Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial

  74. 2015

    The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases.

  75. 2015

    Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR

  76. 2014

    Acute kidney injury after using contrast during cardiac catheterization in children with heart disease

  77. 2014

    Cannabinoids and the Endocannabinoid System in Lower Urinary Tract Function and Dysfunction

  78. 2014

    Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis

    FavorávelEstudo em AnimaisCistiteCanabinoides Sintéticos JWH-x
  79. 2014

    The Effect of Terpene Combination on Ureter Calculus Expulsion After Extracorporeal Shock Wave Lithotripsy

    FavorávelEnsaio ClínicoCálculos Renais
  80. 2014

    TRP channels in lower urinary tract dysfunction

    FavorávelMetanáliseInfecção Urinária
  81. 2013

    Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease

  82. 2013

    Terpene compound drug as medical expulsive therapy for ureterolithiasis: a meta-analysis

    FavorávelMetanáliseCálculos Renais
  83. 2013

    β-caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.

    FavorávelEstudo em AnimaisNefropatia Induzida por Medicamentos
  84. 2012

    Additive renoprotective effects of aliskiren on angiotensin receptor blocker and calcium channel blocker treatments for type 2 diabetic patients with albuminuria

  85. 2012

    Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy.

    FavorávelEstudo em AnimaisNefropatia DiabéticaCanabinoides Sintéticos AM-x
  86. 2012

    Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery

  87. 2012

    L/N-type calcium channel blocker cilnidipine reduces plasma aldosterone, albuminuria, and urinary liver-type fatty acid binding protein in patients with chronic kidney disease

  88. 2011

    Addition of aliskiren to olmesartan ameliorates tubular injury in chronic kidney disease patients partly by reducing proteinuria

  89. 2011

    Biomarkers for early detection of sickle nephropathy

  90. 2011

    Cannabinoids: Potential Targets for Bladder Dysfunction

    FavorávelMetanáliseInfecção Urinária
  91. 2011

    Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy

  92. 2011

    Evaluation of the efficiency of tamsulosin and Rowatinex in patients with distal ureteral stones: a prospective, randomized, controlled study

    InconclusivoEnsaio Clínico Duplo-CegoCálculos Renais
  93. 2011

    Inhibitory effect of standardized cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility

    InconclusivoEstudo LaboratorialInfecção Urinária
  94. 2011

    Is There a Legitimate Role for the Therapeutic Use of Cannabinoids for Symptom Management in Chronic Kidney Disease?

  95. 2011

    Potential benefit of statin therapy for dyslipidemia with chronic kidney disease: Fluvastatin Renal Evaluation Trial (FRET)

  96. 2011

    Renovascular protective effects of erythropoietin in patients with chronic kidney disease

  97. 2010

    Cannabinoid CB1 Receptor Is Downregulated In Clear Cell Renal Cell Carcinoma

    FavorávelEstudo LaboratorialCâncerCâncer — Rim
  98. 2010

    Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress and cell death in nephropathy.

  99. 2010

    CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

  100. 2010

    Increased cannabinoid receptor 1-immunoreactive nerve fibers in overactive and painful bladder disorders and their correlation with symptoms

    FavorávelEstudo LaboratorialInfecção Urinária
  101. 2009

    Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death.

    FavorávelEstudo em AnimaisNefropatia Induzida por Medicamentos
  102. 2009

    Effect of Rowatinex on calculus clearance after extracorporeal shock wave lithotripsy

    FavorávelEnsaio Clínico Duplo-CegoCálculos Renais
  103. 2009

    Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death

  104. 2008

    Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells.

    FavorávelEstudo LaboratorialCâncerCâncer — MelanomaCâncer — Rim
  105. 2006

    The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS).

    FavorávelEnsaio Clínico Duplo-CegoEsclerose MúltiplaInfecção Urinária
  106. 2005

    Cannabis sativa and dystonia secondary to Wilson's disease.

  107. 2004

    An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis

  108. 2003

    A Case of Cannabinoid Rotation in a Young Woman With Chronic Cystitis.

    FavorávelMetanáliseCistiteTetraidrocanabinol (THC)THC Farmacêutico
  109. 2003

    A Preliminary Controlled Study To Determine Whether Whole-plant Cannabis Extracts Can Improve Intractable Neurogenic Symptoms

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaEsclerose Múltipla+2
  110. 1992

    Rowatinex for the treatment of ureterolithiasis

    FavorávelEnsaio Clínico Duplo-CegoCálculos Renais
  111. 1987

    The value of Rowatinex in the treatment of ureterolithiasis

    FavorávelEnsaio Clínico Duplo-CegoCálculos Renais

Continue por aqui

Perguntas frequentes

Quantos estudos sobre sistema urinário estão indexados no acervo?
São 111 estudos, publicados entre 1987 e 2023. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Metanálise: 40 · Ensaio Clínico: 24 · Estudo em Animais: 23 · Estudo Laboratorial: 13 · Ensaio Clínico Duplo-Cego: 9 · Metanálise Clínica: 2. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 90 favoráveis, 14 inconclusivos e 7 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Sistema Urinário — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/sistema/sistema-urinario/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Sistema Urinário — estudos científicos sobre cannabis. https://cannabisindica.com.br/sistema/sistema-urinario/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.